Navigation Links
MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
Date:11/22/2011

SAN DIEGO, Nov. 22, 2011 /PRNewswire/ -- MedVantx, Inc., today announced the deployment of its patent pending Patient Profile™ patient medication and adherence reporting engine across its network of 3,600 high prescribing primary care providers participating in the Company's integrated program of initial free medication therapy, adherence management and home delivery program. This new program utilizes the Company's proprietary automated ATM like sample management system ("MedStart") and an integrated secure web reporting portal to provide physicians visibility to their patients' adherence to chronic medication therapy.  The Platform is designed to help leading medical groups meet the requirements of emerging healthcare reform platforms.

Researchers at Harvard University, Brigham and Women's Hospital and CVS/Caremark announced the results of an important study last week indicating that up to 24% of consumers never fill their initial prescription. "While the results of this study are consistent with previous studies in the area, what is interesting is that prescription abandonment rates appear to be increasing with the growth in electronic prescribing," said Susan Hogue, VP of Managed Care Networks and Clinical Services at MedVantx.  "As Physicians embrace EHR and e-prescribing platforms, they need new tools to help insure medication therapy is initiated and adhered to on an ongoing basis.  Today, physicians have limited access to detailed data about medication samples provided and actual prescriptions filled.  MedVantx has pioneered a program that enables physicians to start all their patients on free prescription medications at the point of care thereby eliminating the potential for abandonment. As a result MedVantx is in a unique position to deliver a complete view of a specific patient's medication program from an initial medication sample to continued fulfillment of chronic medications."

<
'/>"/>
SOURCE MedVantx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
2. MedVantx Honored by Inc. 500/5000 Three Years in a Row
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... has received commitments from institutional investors to purchase ... Company,s common stock in an at-the-market registered direct ... The Company entered into definitive purchase ... Company agreed to sell an aggregate of 3,603,603 ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ... clinical and aesthetic dermatology practitioners in the 21 st ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014 /PRNewswire/ ... such as MRSA, C. difficile and TB in ambulances and ... manufactured by MRSA-UV is now being used by rescue personnel ... prevent EMS paramedics and transport patients from coming in contact ... Fire Rescue is the first in the nation to ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
... 2011 Susquehanna Growth Equity, LLC (SGE) today announced ... a provider of managed care information for the healthcare ... and interpretation of pharmaceutical and healthcare information from health ... in managed markets. In addition, it offers data collection, ...
... SILVER SPRING, Md., April 18, 2011 ... the U.S. Food and Drug Administration. I nformation in ... times for items are current as of April 18, 2011. ... FDA News & Notes does not contain any regulatory or ...
Cached Medicine Technology:Susquehanna Growth Equity Acquires MediMedia Information Technologies, LLC 2Susquehanna Growth Equity Acquires MediMedia Information Technologies, LLC 3FDA News & Notes - Week of April 18, 2011 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... World AIDS day, the Andhra Pradesh State AIDS Control Society (APSACS) ... rally which was participated by students from school and ... that in the year 2004, more than 4.9 million people are ... it is estimated that by 2010 more than 75 million people ...
... Institute of Environmental Health Sciences (NIEHS), conducted a study ... starch predisposes to respiratory problems. // ,"These ... Stephanie London, M.D., lead investigator on the study. "We ... data from such a large number of participants to ...
... health sector of England has both doctors and nurses of ... almost 20 percent.// The National Health Service (NHS) of ... Children's Hospital, in the Wellchild awards. ,Jaswant ... has been honoured in a national competition. Children's health charity ...
... worded news the Centre for Science in the Public Interest, ... to ban the sale of - the fake meat made from ... found to induce vomiting and many people fell ill. ... with fungi based 'mycoprotein.' That ingredient springs from a single-celled fungus. ...
... A research conducted by the University of Alberta has revealed ... men and women, while performing the same tasks. This goes ... women really do work differently. The volunteers for the study ... tasks, verbal tasks, and memory tasks, while the functional Magnetic ...
... dynamic process. It helps us to retrieve information from different areas ... of Molecular and Cellular biology at Baylor college of Medicine (BCM) ... is a chemical change in the tissue representing the formation of ... only after 30 minutes mediated by the gene amnesiac but lasted ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: